Lista de obras -

14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens.

artículo científico publicado en 2007

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

artículo científico publicado en 2002

Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer.

artículo científico publicado en 2011

Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer.

artículo científico publicado en 2006

An androgen receptor N-terminal domain antagonist for treating prostate cancer.

artículo científico publicado en 2013

An imaging agent to detect androgen receptor and its active splice variants in prostate cancer

scientific article published on July 2016

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.

artículo científico publicado en 2005

Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.

artículo científico publicado en 2006

Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy

artículo científico publicado en 2018

Androgen receptor and its splice variants in prostate cancer

artículo científico publicado en 2011

Androgen receptor decoy molecules block the growth of prostate cancer

artículo científico publicado en 2007

Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic.

artículo científico publicado en 2016

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways

artículo científico publicado en 1999

Androgenic Induction of Prostate-specific Antigen Gene Is Repressed by Protein-Protein Interaction between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP ⬇️

artículo científico publicado el 11 de julio de 1997

Androgens and androgen receptor in prostate and ovarian malignancies.

artículo científico publicado en 2003

Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model

scientific article published on 01 June 1998

Characterization of niphatenones that inhibit androgen receptor N-terminal domain

artículo científico publicado en 2014

Combination therapy with androgen receptor N-terminal domain antagonist EPI-7170 and enzalutamide yields synergistic activity in AR-V7-positive prostate cancer

artículo científico publicado en 2020

Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.

artículo científico publicado en 2009

Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer

artículo científico publicado en 2015

Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.

artículo científico publicado en 2010

Directing abiraterone metabolism: balancing the scales between clinical relevance and experimental observation

scientific article published on 01 September 2016

Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor

artículo científico publicado en 2020

Does increased expression of glucocorticoid receptor support application of antagonists to this receptor for the treatment of castration resistant prostate cancer?

artículo científico publicado en 2018

Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens

artículo científico publicado en 2018

FUS/TLS is a co-activator of androgen receptor in prostate cancer cells

artículo científico publicado en 2011

Incarnatapeptins A and B, Nonribosomal Peptides Discovered Using Genome Mining and 1H/15N HSQC-TOCSY

artículo científico publicado en 2020

Induction of CYP1A1 by GABA receptor ligands

artículo científico publicado en 1996

Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer

artículo científico publicado en 2009

Isolation and characterization of castration-resistant prostate cancer LNCaP95 clones

scientific article published on 20 September 2020

LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer

artículo científico publicado en 2010

Large scale phosphoproteome analysis of LNCaP human prostate cancer cells

artículo científico publicado en 2012

N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy

artículo científico publicado en 2014

Niphatenones, glycerol ethers from the sponge Niphates digitalis block androgen receptor transcriptional activity in prostate cancer cells: structure elucidation, synthesis, and biological activity.

artículo científico publicado en 2011

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

artículo científico publicado en 2017

Order within a Disordered Structure.

artículo científico publicado en 2018

Osteoblast-derived factors induce an expression signature that identifies prostate cancer metastasis and hormonal progression.

artículo científico publicado en 2009

Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells.

artículo científico publicado en 2004

Phenobarbital induction of CYP1A1 gene expression in a primary culture of rainbow trout hepatocytes.

artículo científico publicado en 1996

Phenobarbital induction of cytochrome P4501A1 is regulated by cAMP-dependent protein kinase-mediated signaling pathways in rainbow trout hepatocytes

scientific article published on 01 August 1996

Picrotoxin is a CYP1A1 inducer in rainbow trout hepatocytes

scientific article published on 01 September 1995

Prostate cancer: molecular biology of early progression to androgen independence.

artículo científico publicado en 1999

Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants

scientific article published on 21 July 2020

Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor

artículo científico publicado en 2010

Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain.

artículo científico publicado en 2016

Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells.

artículo científico publicado en 2008

Small molecule inhibitors targeting the "achilles' heel" of androgen receptor activity

artículo científico publicado en 2011

Spongian diterpenoids inhibit androgen receptor activity

artículo científico publicado en 2013

Structure-Activity Relationships for the Marine Natural Product Sintokamides: Androgen Receptor N-Terminus Antagonists of Interest for Treatment of Metastatic Castration-Resistant Prostate Cancer

scientific article published on 30 October 2020

Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer

artículo científico publicado en 2016

Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer.

artículo científico publicado en 2016

Lista de obras de

14-3-3 sigma increases the transcriptional activity of the androgen receptor in the absence of androgens.

Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways

Advances in small molecule inhibitors of androgen receptor for the treatment of advanced prostate cancer.

Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer.

An androgen receptor N-terminal domain antagonist for treating prostate cancer.

An imaging agent to detect androgen receptor and its active splice variants in prostate cancer

An orthotopic metastatic prostate cancer model in SCID mice via grafting of a transplantable human prostate tumor line.

Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach.

Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy

Androgen receptor and its splice variants in prostate cancer

Androgen receptor decoy molecules block the growth of prostate cancer

Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic.

Androgen-independent induction of prostate-specific antigen gene expression via cross-talk between the androgen receptor and protein kinase A signal transduction pathways

Androgenic Induction of Prostate-specific Antigen Gene Is Repressed by Protein-Protein Interaction between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP ⬇️

Androgens and androgen receptor in prostate and ovarian malignancies.

Butyrate analogue, isobutyramide, inhibits tumor growth and time to androgen-independent progression in the human prostate LNCaP tumor model

Characterization of niphatenones that inhibit androgen receptor N-terminal domain

Combination therapy with androgen receptor N-terminal domain antagonist EPI-7170 and enzalutamide yields synergistic activity in AR-V7-positive prostate cancer

Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection.

Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer

Development of metastatic and non-metastatic tumor lines from a patient's prostate cancer specimen-identification of a small subpopulation with metastatic potential in the primary tumor.

Directing abiraterone metabolism: balancing the scales between clinical relevance and experimental observation

Discovery of drugs that directly target the intrinsically disordered region of the androgen receptor

Does increased expression of glucocorticoid receptor support application of antagonists to this receptor for the treatment of castration resistant prostate cancer?

Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens

FUS/TLS is a co-activator of androgen receptor in prostate cancer cells

Incarnatapeptins A and B, Nonribosomal Peptides Discovered Using Genome Mining and 1H/15N HSQC-TOCSY

Induction of CYP1A1 by GABA receptor ligands

Induction of neuronal apoptosis inhibitory protein expression in response to androgen deprivation in prostate cancer

Isolation and characterization of castration-resistant prostate cancer LNCaP95 clones

LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer

Large scale phosphoproteome analysis of LNCaP human prostate cancer cells

N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy

Niphatenones, glycerol ethers from the sponge Niphates digitalis block androgen receptor transcriptional activity in prostate cancer cells: structure elucidation, synthesis, and biological activity.

Non-Genomic Actions of the Androgen Receptor in Prostate Cancer

Order within a Disordered Structure.

Osteoblast-derived factors induce an expression signature that identifies prostate cancer metastasis and hormonal progression.

Osteoblast-derived factors induce androgen-independent proliferation and expression of prostate-specific antigen in human prostate cancer cells.

Phenobarbital induction of CYP1A1 gene expression in a primary culture of rainbow trout hepatocytes.

Phenobarbital induction of cytochrome P4501A1 is regulated by cAMP-dependent protein kinase-mediated signaling pathways in rainbow trout hepatocytes

Picrotoxin is a CYP1A1 inducer in rainbow trout hepatocytes

Prostate cancer: molecular biology of early progression to androgen independence.

Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants

Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor

Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain.

Sintokamides A to E, chlorinated peptides from the sponge Dysidea sp. that inhibit transactivation of the N-terminus of the androgen receptor in prostate cancer cells.

Small molecule inhibitors targeting the "achilles' heel" of androgen receptor activity

Spongian diterpenoids inhibit androgen receptor activity

Structure-Activity Relationships for the Marine Natural Product Sintokamides: Androgen Receptor N-Terminus Antagonists of Interest for Treatment of Metastatic Castration-Resistant Prostate Cancer

Targeting Androgen Receptor Activation Function-1 with EPI to Overcome Resistance Mechanisms in Castration-Resistant Prostate Cancer

Targeting the N-Terminal Domain of the Androgen Receptor: A New Approach for the Treatment of Advanced Prostate Cancer.